EIF3C and head and neck squamous cell carcinoma: Through a xenograft murine model of head and neck squamous cell carcinoma (HNSCC), it is successfully demonstrated that Iacs-eif3c-RNA effectively overcame the pharmacological barrier associated with eIF3C, significantly reduced the expression level of eIF3C in tumor tissues and exhibited inhibitory effects on tumor growth in vivo.